Andy Hahn/X
Jun 9, 2024, 12:59
Andy Hahn: Check out our editorial on CV risk in men with prostate cancer treated with ADT
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Centre, shared on X:
“Check out our editorial on CV risk in men with prostate cancer treated with ADT.
We discuss the need to develop risk models specific to men with PCa and to better understand the biologic determinants of toxicity.”
Source: Andy Hahn/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 14:05
Nov 14, 2024, 13:49
Nov 14, 2024, 13:44
Nov 14, 2024, 13:37
Nov 14, 2024, 13:32
Nov 14, 2024, 13:29